Fuhrman Alan

CIK 00013035218 companiesSAN DIEGO, CA

SEC Profile

Transactions

Companies

Filings

CIK

0001303521

Recent Transactions

50 trades

Award
Tyra Biosciences, Inc.$TYRA
Common Stock
2025-09-15$9.13/sh+701→ 14,788 total
Award
Tyra Biosciences, Inc.$TYRA
Stock Option (Right to Buy)
2025-08-07+170,000→ 170,000 total
Disposition to Issuer
SpringWorks Therapeutics, Inc.
Stock Option (Right to Buy)
2025-07-01−13,774→ 0 total
Disposition to Issuer
SpringWorks Therapeutics, Inc.
Stock Option (Right to Buy)
2025-07-01−29,983→ 0 total
Disposition to Issuer
SpringWorks Therapeutics, Inc.
Stock Option (Right to Buy)
2025-07-01−15,318→ 0 total
Disposition to Issuer
SpringWorks Therapeutics, Inc.
Stock Option (Right to Buy)
2025-07-01−7,464→ 0 total
Disposition to Issuer
SpringWorks Therapeutics, Inc.
Stock Option (Right to Buy)
2025-07-01−12,216→ 0 total
Disposition to Issuer
SpringWorks Therapeutics, Inc.
Common Stock
2025-07-01−24,727→ 0 total
Award
SpringWorks Therapeutics, Inc.
Common Stock
2025-05-14+10,060→ 24,727 total
Award
Tyra Biosciences, Inc.$TYRA
Common Stock
2025-03-14$9.78/sh+1,238→ 14,087 total
Purchase
Tyra Biosciences, Inc.$TYRA
Common Stock
2024-10-30$16.00/sh+9,500→ 12,849 total
Award
Tyra Biosciences, Inc.$TYRA
Common Stock
2024-09-13$12.48/sh+954→ 3,349 total
Award
Tyra Biosciences, Inc.$TYRA
Stock Option (Right to Buy)
2024-08-14+115,000→ 115,000 total
Award
Esperion Therapeutics, Inc.$ESPR
Stock Option (right to buy)
2024-05-23+32,500→ 32,500 total
Award
Esperion Therapeutics, Inc.$ESPR
Common Stock
2024-05-23+23,000→ 53,404 total
Award
SpringWorks Therapeutics, Inc.
Common Stock
2024-05-16+4,095→ 14,667 total
Award
SpringWorks Therapeutics, Inc.
Stock Option (Right to Buy)
2024-05-16+12,216→ 12,216 total
Award
Tyra Biosciences, Inc.$TYRA
Common Stock
2024-03-15$12.48/sh+932→ 2,395 total
Award
Tyra Biosciences, Inc.$TYRA
Common Stock
2023-09-15$12.50/sh+1,463→ 1,463 total
Award
Tyra Biosciences, Inc.$TYRA
Stock Option (Right to Buy)
2023-07-28+62,685→ 62,685 total
Award
Esperion Therapeutics, Inc.$ESPR
Common Stock
2023-06-15+5,150→ 30,404 total
Award
Esperion Therapeutics, Inc.$ESPR
Stock Option (right to buy)
2023-06-15+21,000→ 21,000 total
Award
SpringWorks Therapeutics, Inc.
Stock Option (Right to Buy)
2023-05-24+13,774→ 13,774 total
Award
SpringWorks Therapeutics, Inc.
Common Stock
2023-05-24+4,648→ 10,572 total
Award
Tyra Biosciences, Inc.$TYRA
Stock Option (Right to Buy)
2023-01-01+328,000→ 328,000 total
Award
Tyra Biosciences, Inc.$TYRA
Stock Option (Right to Buy)
2023-01-01+32,800→ 32,800 total
Disposition to Issuer
Checkmate Pharmaceuticals, Inc.
Stock Option (Right to Buy)
2022-05-31−22,736→ 0 total
Disposition to Issuer
Checkmate Pharmaceuticals, Inc.
Stock Option (Right to Buy)
2022-05-31−10,030→ 0 total
Disposition to Issuer
Checkmate Pharmaceuticals, Inc.
Stock Option (Right to Buy)
2022-05-31−246,671→ 0 total
Award
Esperion Therapeutics, Inc.$ESPR
Stock Option (right to buy)
2022-05-26+20,000→ 20,000 total
Award
SpringWorks Therapeutics, Inc.
Stock Option (Right to Buy)
2022-05-19+15,318→ 15,318 total
Award
SpringWorks Therapeutics, Inc.
Common Stock
2022-05-19+4,818→ 5,924 total
Award
Checkmate Pharmaceuticals, Inc.
Stock Option (Right to Buy)
2021-10-27+246,671→ 246,671 total
Award
Checkmate Pharmaceuticals, Inc.
Stock Option (Right to Buy)
2021-06-16+10,030→ 10,030 total
Award
Esperion Therapeutics, Inc.$ESPR
Common Stock
2021-05-27+12,376→ 25,254 total
Award
SpringWorks Therapeutics, Inc.
Common Stock
2021-05-20+1,106→ 25,227 total
Award
SpringWorks Therapeutics, Inc.
Stock Option (Right to Buy)
2021-05-20+6,998→ 6,998 total
Award
Esperion Therapeutics, Inc.$ESPR
Common Stock
2020-05-28+1,221→ 12,878 total
Award
SpringWorks Therapeutics, Inc.
Stock Option (Right to Buy)
2020-05-20+7,464→ 7,464 total
Award
Esperion Therapeutics, Inc.$ESPR
Common Stock
2020-05-15+11,003→ 11,657 total
Award
SpringWorks Therapeutics, Inc.
Stock Option (Right to Buy)
2019-09-12+29,983→ 29,983 total
Disposition to Issuer
Loxo Oncology, Inc.
Employee Stock Option (Right to Buy)
2019-02-15$235.00/sh−11,000→ 0 total
Disposition to Issuer
Loxo Oncology, Inc.
Employee Stock Option (Right to Buy)
2019-02-15$235.00/sh−8,750→ 0 total
Disposition to Issuer
Loxo Oncology, Inc.
Employee Stock Option (Right to Buy)
2019-02-15$235.00/sh−7,812→ 0 total
Disposition to Issuer
Loxo Oncology, Inc.
Employee Stock Option (Right to Buy)
2019-02-15$235.00/sh−7,812→ 0 total
Disposition to Issuer
Loxo Oncology, Inc.
Employee Stock Option (Right to Buy)
2019-02-15$235.00/sh−13,000→ 0 total
Award
Loxo Oncology, Inc.
Director Stock Option (right to buy)
2018-06-13+8,750→ 8,750 total
Sale
Loxo Oncology, Inc.
Common Stock
2018-06-08$178.07/sh−2,625→ 0 total
Exercise/Conversion
Loxo Oncology, Inc.
Director Stock Option (right to buy)
2018-06-08−2,625→ 13,000 total
Exercise/Conversion
Loxo Oncology, Inc.
Common Stock
2018-06-08$11.35/sh+2,625→ 2,625 total

Fuhrman Alan

Recent Transactions

Companies

Recent Filings

Address